Our group leads pre-seed round into Sussex MedTech startup Athos

South East Angels, a prominent angel group specializing in early-stage ventures across the South East, is excited to announce its recent investment in Athos Medtech, a cutting-edge MedTech startup that is revolutionizing drug delivery.

Athos has developed a unique medical device and drug-heating technology aimed at significantly improving the effectiveness of inhalers by increasing drug delivery from 30% to an impressive 90%. Founded by Dr. Stuart Gibson, a junior doctor and clinical innovator, Athos Medtech is committed to advancing medical diagnostics and treatment equipment on a national and international scale.

Driven by a passion for enhancing patient outcomes, the company aims to address the limitations of current drug delivery methods and provide a groundbreaking solution. The funds raised from this pre-seed Angel round will be utilised to accelerate the development and commercialization of the technology.

“South East Angels recognizes the immense potential of Athos Medtech and is delighted to support their mission of transforming drug delivery in the healthcare industry. We firmly believe in the team's vision and ability to revolutionise this landscape.” - Kristina Pereckaite, Managing Director, South East Angels.

With the backing of South East Angels, Athos Medtech is well-positioned to make a significant impact on patient care and medical innovation. The funding marks a significant milestone in the journey of Athos as it strives to improve drug delivery and enhance the lives of countless individuals worldwide.